Skip to content

The FDA is reviewing the Johnson & Johnson COVID-19 vaccine and may get emergency clearance by the end of the week. Unlike Moderna and Pfizer vaccines, this one only requires one injection. Josh Michaud, associate director of global health policy at the Kaiser Family Foundation, joined “CBSN AM” to discuss its importance.


Source link